Dr. Olin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
I am retired
Burlington, VT 05403- Is this information wrong?
Education & Training
University of Vermont Medical CenterFellowship, Hematology and Medical Oncology, 1989 - 1992- University of Vermont Medical CenterResidency, Internal Medicine, 1985 - 1988
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1985
Certifications & Licensure
VT State Medical License 1988 - 2024
Publications & Presentations
PubMed
- 11 citationsPhase I/II trial of adjuvant dose-dense docetaxel/epirubicin/cyclophosphamide (TEC) in stage II and III breast cancer.Susan Burdette-Radoux, Marie E. Wood, Julie J. Olin, Rebecca S. Laughlin, Abigail Crocker, Takamaru Ashikaga, Hyman B. Muss> ;The Breast Journal. 2007 May 1
- Phase I/II feasibility trial of adjuvant dose-dense (DD) docetaxel/epirubicin/cyclophosphamide (TEC) in stage II/III breast cancer.Burdette-Radoux S, Wood ME, Olin JJ, Broom R, Crocker A, Ashikaga T, Muss HB> ;J. Clin. Oncol.. 2005-06-01
- 67 citationsCognitive function after systemic therapy for breast cancer.Julie J. Olin> ;Oncology. 2001 May 1
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
University of Vermont Medical CenterBurlington, Vermont
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
